InvestorsHub Logo
Followers 0
Posts 105
Boards Moderated 0
Alias Born 02/05/2006

Re: read_this_n0w post# 2986

Saturday, 09/09/2006 10:25:32 AM

Saturday, September 09, 2006 10:25:32 AM

Post# of 6489
I had previously reviewed the EMEA guidelines and believed that it could benefit INSM. There has always been a question regarding TRCA's clinical trials and maybe the EU would ask for additional info. considering the known risks of naked IGF-1. If Increlex's approval is delayed then it screws up all their plans with Ipsen.


On a side note - I contacted TRCA by e-mail several weeks ago and asked for a clarification on the EU approval process for Increlex. Never got a response by phone or e-mail. Has anyone else attempted to contact TRCA's IR?

Doesn't someone on this board have a contact with INSM's IR? I bet they could straighten us out since we've been going in circles for the last month on this issue.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News